Philips Is Now Discontinuing Certain Devices, Including Its CPAP Machine, After Painful Year of Recalls

Sleepopolis | By Alexandra Frost

On the heels of ongoing legal troubles with product recalls, Philips Respironics recently announced on the company’s website that it is updating its portfolio, and it will no longer manufacture certain home and hospital ventilation systems, certain oxygen concentrators, and sleep diagnostic devices (1). This includes the DreamStation Portable PAP Therapy System (CPAP), among others.

This announcement affects the U.S. and U.S. Territory customers, and comes amidst a Congressional inquiry into the possibility that the company withheld complaints from the FDA about their CPAP, BiPap, and ventilators (2, 3). The inquiry also claims that Philips Respironics failed to notify patients and providers about the dangerous nature of their product for over 11 years. 

The company states on its website that, “Philips Respironics will focus on the sale of consumables and accessories, including masks, and will not return to the sale of hospital ventilation products, certain home ventilation products, portable and stationary oxygen concentrators and sleep diagnostic products.” The company also goes on to say that this discontinuation will not impact their “commitment to the remediation of devices impacted by the June 2021 recall of certain CPAP, BiPAP and mechanical ventilator devices.”

[Click here] to read which products are impacted by this discontinuation